Central nervous system infection following allogeneic hematopoietic stem cell transplantation
Hematology/Oncology and Stem Cell Therapy · 2017-01 · 10 (1) · 22-28
DOI: 10.1016/j.hemonc.2016.08.008 ↗Abstract
Objective/background: Here, we described the clinical characteristics and outcomes of central nervous system (CNS) infections occurring after allogeneic hematopoietic stem cell transplantation (allo-HSCT) in a single institution over the previous 6 years. Methods: Charts of 353 consecutive allogeneic transplant recipients were retrospectively reviewed for CNS infection. Results: A total of 17 cases of CNS infection were identified at a median of 38 days (range, 10– 1028 days) after allo-HSCT. Causative pathogens were human herpesvirus-6 ( n = 6), enterococcus ( n = 2), staphylococcus ( n = 2), streptococcus ( n = 2), varicella zoster virus ( n = 1), cytomegalovirus ( n = 1), John Cunningham virus ( n = 1), adenovirus ( n = 1), and Toxoplasma gondii ( n = 1). The cumulative incidence of CNS infection was 4.1% at 1 year and 5.5% at 5 years. Conclusion: Multivariate analysis revealed that high-risk disease status was a risk factor for developing CNS infection ( p = .02), and that overall survival at 3 years after allo-HSCT was 33% in patients with CNS infection and 53% in those without CNS infection ( p = .04).
EUVIMED